Photoacoustic PDA-ICG Nanoprobe for Detecting Senescent Cells in Cancer

A study in Scientific Reports evaluated a photoacoustic polydopamine-indocyanine green (PDA-ICG) nanoprobe for detecting senescent cells. Senescent cells play a role in tumor progression and therapeutic resistance, with potential adverse effects such as inflammation and tissue disruption. The PDA-ICG nanoprobe offers a method for identifying these cells, with implications for cancer diagnostics and treatment.

Background

Cellular senescence is a stable cell cycle arrest triggered by stressors such as DNA damage, oxidative stress, and oncogenic signaling. Senescent cells produce pro-inflammatory cytokines, growth factors, and proteases, collectively known as the senescence-associated secretory phenotype (SASP).

This phenomenon contributes to tumor progression and age-related diseases. Accurately identifying and visualizing these cells in vivo is crucial for understanding their role in cancer biology and developing targeted therapies.

Traditional methods for detecting senescent cells, such as β-galactosidase staining and immunohistochemistry, have limitations in terms of specificity and sensitivity. The introduction of advanced imaging techniques, particularly those utilizing nanoprobes, offers a promising avenue for enhancing the detection of senescent cells.

The PDA-ICG nanoprobe combines the photothermal properties of polydopamine with the fluorescence of indocyanine green, enabling both photoacoustic imaging and fluorescence imaging. This dual functionality is expected to improve the visualization of senescent cells.

The Current Study

The study used experimental techniques to evaluate the performance of the PDA-ICG nanoprobe. Human cancer cell lines, A549 and SK-MEL-103, were cultured and treated with varying concentrations of PDA-ICG to assess cell viability and nanoprobe internalization.

The MTS assay measured cell viability after treatment, and flow cytometry assessed nanoprobe internalization in live cells. After treatment, cells were washed to remove excess probes and stained with DAPI for flow cytometric analysis. Data were processed using FlowJo software to identify live, single-cell populations with internalized nanoprobe.

Cells were treated with chemotherapeutic agents, cisplatin and palbociclib, for a specified duration. After drug removal, the cells were stained with β-galactosidase to identify senescent cells. RNA extraction and quantitative real-time PCR (RT-qPCR) were performed to measure the expression levels of senescence-associated genes.

Western blotting was conducted to analyze protein expression related to senescence, including p21 and pRb. Confocal microscopy was utilized to visualize the cellular localization of the PDA-ICG nanoprobe and assess its potential for imaging senescent cells.

Results and Discussion

The results showed that the PDA-ICG nanoprobe was successfully internalized into cancer cells, with flow cytometry confirming significantly higher uptake in treated cells than controls. The MTS assay indicated no adverse effects on cell viability at the tested concentrations, supporting its potential for safe in vivo application.

The study also found that treatment with cisplatin and palbociclib successfully induced senescence in the respective cell lines, as evidenced by increased β-galactosidase activity. The expression of senescence-associated genes was significantly elevated in treated cells, further confirming the induction of senescence.

Confocal microscopy highlighted the PDA-ICG nanoprobe’s imaging capabilities, revealing distinct localization patterns within the cells. The nanoprobe’s dual imaging modality allowed for more precise visualization of senescent cells than traditional methods. The findings suggest that the PDA-ICG nanoprobe could serve as a valuable tool for studying the dynamics of senescence in cancer and other diseases.

The ability to visualize senescent cells in real time may facilitate the development of targeted therapies that eliminate these cells from the tumor microenvironment, potentially improving patient outcomes.

Conclusion

The study successfully demonstrated the utility of the PDA-ICG nanoprobe for detecting senescent cells in cancer. Combining the advantages of photoacoustic and fluorescence imaging, this innovative approach offers a promising strategy for enhancing the visualization of senescence in vivo. The findings underscore the importance of accurately identifying senescent cells in the context of cancer biology and therapeutic interventions.

Future research should focus on optimizing the nanoprobe for clinical applications and exploring its potential in various cancer models. The ability to monitor senescence dynamically could lead to significant advancements in cancer diagnostics and treatment, ultimately contributing to improved patient care and outcomes.

Journal Reference

Hartono, M., et al. (2024). Photoacoustic polydopamine-indocyanine green (PDA-ICG) nanoprobe for detection of senescent cells. Scientific Reports. DOI: 10.1038/s41598-024-79667-7, https://www.nature.com/articles/s41598-024-79667-7